Humana (HUM) shares were down about 22% in Wednesday's premarket activity after it disclosed in a regulatory filing that the number of members enrolled for 2025 in its Medicare Advantage Plans rated four stars or higher fell to 25%, or 1.6 million, from 94% in 2024.
The company said a driver of these results was one of its contracts with 45% of its Medicare Advantage members decreasing to a 3.5-star rating from a 4.5 star rating.
The company said its 2025 stars results are not expected to impact the company's financial results or outlook for 2024 or 2025. It is attempting to challenge some of the numbers that led to the decline, the company added.
Humana said in the regulatory filing that it is "disappointed with its performance and has initiatives underway focused on improving its operating discipline and returning to an industry-leading stars position as quickly as possible."
Price: 217.99, Change: -61.46, Percent Change: -21.99
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。